Pharmacovigilance study of ramucirumab: A safety analysis based on the FDA adverse event reporting system
{{output}}
Background: This study analyzes adverse event (AE) signals associated with ramucirumab using data from the FDA Adverse Event Reporting System (FAERS) to provide evidence supporting the safety of the drug for clinical use. ... ...
